Knight Therapeutics Inc

TSX:GUD (Canada)  
C$ 5.38 (+1.51%) Mar 18
At Loss
P/B:
0.69
Market Cap:
C$ 561.46M ($ 414.53M)
Enterprise V:
C$ 460.53M ($ 340.01M)
Volume:
59.58K
Avg Vol (2M):
69.83K
Also Trade In:
Volume:
59.58K
At Loss
Avg Vol (2M):
69.83K

Business Description

Description
Knight Therapeutics Inc is a specialty and generic drug manufacturing company. The company's principal business activity is focused on developing, acquiring, in-licensing, out-licensing, marketing, and distributing pharmaceutical products, consumer health products, and medical devices in Canada, Ltin America and select international markets. Knight finances other life sciences companies across the globe in order to generate interest income, strengthen relationships in the life sciences industry, and to secure product distribution rights.
Name Current Vs Industry Vs History
Cash-To-Debt 2.23
Equity-to-Asset 0.81
Debt-to-Equity 0.1
Debt-to-EBITDA 1.61
Piotroski F-Score 6/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 2.57
Distress
Grey
Safe
Beneish M-Score -2.45
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 54.79
9-Day RSI 47.65
14-Day RSI 46.92
6-1 Month Momentum % 25.96
12-1 Month Momentum % 12.73

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 3.49
Quick Ratio 2.51
Cash Ratio 1.59
Days Inventory 197.36
Days Sales Outstanding 101
Days Payable 194.81

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio 6.1
Shareholder Yield % 0.69

Financials (Next Earnings Date:2024-03-21)

TSX:GUD's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Knight Therapeutics Inc Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil C$) 335.657
EPS (TTM) (C$) -0.06
Beta 0.33
Volatility % 22.48
14-Day RSI 46.92
14-Day ATR (C$) 0.117712
20-Day SMA (C$) 5.4275
12-1 Month Momentum % 12.73
52-Week Range (C$) 4.28 - 5.75
Shares Outstanding (Mil) 104.36

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 6
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Knight Therapeutics Inc Filings

Filing Date Document Date Form
No Filing Data

Knight Therapeutics Inc Stock Events

Financials Calendars
Event Date Price(C$)
No Event Data

Knight Therapeutics Inc Frequently Asked Questions

What is Knight Therapeutics Inc(TSX:GUD)'s stock price today?
The current price of TSX:GUD is C$5.38. The 52 week high of TSX:GUD is C$5.75 and 52 week low is C$4.28.
When is next earnings date of Knight Therapeutics Inc(TSX:GUD)?
The next earnings date of Knight Therapeutics Inc(TSX:GUD) is 2024-03-21.
Does Knight Therapeutics Inc(TSX:GUD) pay dividends? If so, how much?
Knight Therapeutics Inc(TSX:GUD) does not pay dividend.

Press Release

Subject Date
No Press Release